Reformation Files for NYSE IPO with Price Range of $15 to $17 Per Share
Reformation Inc. has filed for an initial public offering of approximately 14.06 million shares on the New York Stock Exchange, aiming to raise up to $239 million.
Latest by Marcus Chen
Boxabl Stock Jumps 20% in Nasdaq Debut After SPAC Merger
Shares of modular housing manufacturer Boxabl Inc. (NASDAQ: BXBL) surged in their first day of public trading after the company completed its business combination with FG Merger II Corp.
Clariant Downgraded by Morgan Stanley on Catalyst Division Risks, Legal Overhang
Morgan Stanley has downgraded Clariant to 'underweight,' citing significant near-term earnings risk in its key Catalyst business and a major legal overhang from ethylene price-fixing litigation, prompting a more than 5% drop in the company's shares.
Broadcom Stock Rebounds on Analyst Support and AI Optimism
Broadcom shares rose in pre-market trading, recovering from a sharp weekly decline after a Morgan Stanley note highlighted the semiconductor selloff as a buying opportunity amid strong AI demand.
AMC Shares Surge on Record Q2 Revenue and EBITDA
AMC Entertainment shares soared in pre-market trading after the company announced its highest-ever quarterly revenue and adjusted EBITDA, significantly beating Wall Street expectations.
Reformation Targets $15-$17 Share Price in New York Stock Exchange IPO
The Los Angeles-based womenswear brand is launching its roadshow to offer 14.1 million shares on the NYSE under the ticker 'REF', with a portion of the shares being sold by existing stockholders.
Scribe Therapeutics Files for IPO, Targeting $100 Million Raise
Biotechnology firm Scribe Therapeutics Inc. has filed for an initial public offering of 7.15 million shares, aiming to raise approximately $100 million at the midpoint of its proposed price range.
Alphabet Q2 Earnings: Investors Weigh Cloud Strength Against AI Execution Risks
Alphabet is set to report Q2 2026 earnings on July 22, with investors balancing a massive cloud backlog and strong beat history against concerns over AI product delays and talent departures.
Morgan Stanley Identifies Emerging Catalysts in Latin American Markets
Analysts at Morgan Stanley see potential investment opportunities emerging in Brazil, Mexico, and Argentina, noting that regional equities are trading at a discount while global investor positioning remains historically low.